- Home
- MHH vs MIST Comparison
MHH vs MIST Comparison
Compare MHH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | MIST |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.1M | 176.3M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MHH | MIST |
|---|---|---|
| Price | $7.75 | $1.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 27.7K | ★ 1.4M |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $191,371,000.00 | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | $9.07 | N/A |
| P/E Ratio | $394.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.51 | $1.00 |
| 52 Week High | $8.37 | $3.06 |
Technical Indicators
Market Signals| Indicator | MHH | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 61.90 | 45.54 |
| Support Level | $6.64 | $1.20 |
| Resistance Level | $8.37 | $1.42 |
| Average True Range (ATR) | 0.48 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 86.42 | 54.55 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).